Sarconeos
Tier C — Watch / tradeSarconeos
Targets：MAS
Brand：Sarconeos
Indications (approved)：肌肉减少症, Overweight, Obesity, 肌肉萎缩, Duchenne muscular dystrophy
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| BIO-101-001 | 27948-74-9 | (6R,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)-4,5,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-6-ol |
| BIO-101-002 | 264925-82-8 | 2-(((6R,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)-4,5,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-6-yl)oxy)tetrahydro-2H-pyran |
| BIO-101-003 | 264925-83-9 | (1R,3aS,3bS,5R,6aS,7aR,8aR,8bS,10aR)-8a,10a-dimethyl-1-((R)-6-methylheptan-2-yl)-5-((tetrahydro-2H-pyran-2-yl)oxy)hexadecahydro-1H-cyclopenta[7,8]phenanthro[2,3-b]oxirene |
| BIO-101-004 | 264925-84-0 | (2S,3R,6R,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)-6-((tetrahydro-2H-pyran-2-yl)oxy)hexadecahydro-1H-cyclopenta[a]phenanthren-2-d-3-ol |
| BIO-101-005 | 264925-85-1 | (2S,6R,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)-6-((tetrahydro-2H-pyran-2-yl)oxy)hexadecahydro-3H-cyclopenta[a]phenanthren-3-one-2-d |
| BIO-101-006 | 264925-86-2 | (2S,3S,6R,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)-6-((tetrahydro-2H-pyran-2-yl)oxy)hexadecahydro-1H-cyclopenta[a]phenanthren-2-d-3-ol |
| BIO-101-007 | 264925-87-3 | (2S,3S,6R,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)-6-((tetrahydro-2H-pyran-2-yl)oxy)hexadecahydro-1H-cyclopenta[a]phenanthren-3-yl-2-d acetate |
| BIO-101-008 | 264925-88-4 | (2S,3S,6R,8S,9S,10R,13R,14S,17R)-6-hydroxy-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-3-yl-2-d acetate |
| BIO-101-009 | 264925-89-5 | (2S,3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl-2-d acetate |
| BIO-101-010 | 54594-70-6 | (2S,3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-2-d-3-ol |
| BIO-101 | 5289-74-7 | (2S,3R,5R,9R,10R,13R,14S,17S)-2,3,14-trihydroxy-10,13-dimethyl-17-((2R,3R)-2,3,6-trihydroxy-6-methylheptan-2-yl)-1,2,3,4,5,9,10,11,12,13,14,15,16,17-tetradecahydro-6H-cyclopenta[a]phenanthren-6-one |
Frequently asked questions
What are the approved indications of Sarconeos?
Approved indications include: 肌肉减少症, Overweight, Obesity, 肌肉萎缩, Duchenne muscular dystrophy.
When does the Sarconeos patent expire?
No public expiry year is available for Sarconeos yet; this page updates once verified.
How many synthesis routes are recorded for Sarconeos?
1 synthesis routes are recorded; the shortest is 10 steps with 6.0 mg (BIO-101) total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Sarconeos intermediates?
All intermediates in Sarconeos routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for Sarconeos intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-03